DPYSL2 and juvenile neuronal ceroid lipofuscinosis: While (S)-Lacosamide has been previously shown to reduce p-CRMP2 levels at the studied dose [16], the phosphorylation status of CRMP2 in Batten disease has not been explored, though the total level of CRMP2 is reduced in Cln6nclf brains [7,16].